In conjunction with the Jan. 1 California Senate Bill 367, which aims to end opioid overdoses at public colleges and universities in the state by requiring them to keep opioid reversal drugs on campus, the California Department of Public Health, or CDPH, has attempted to increase access to Naloxone, one such reversal drug.